The novel T2D risk loci may involve genes that are implicated in insulin sensitivity and control of glucagon and insulin secretion: PTPRD may participate in the regulation of insulin action on its target cells, while SRR variants may alter glutamate signaling in the pancreas, thus regulating insulin and/or glucagon secretion. This evidence concerns the gene SRR and type 2 diabetes mellitus.